History | Cabozantinib for untreated advanced renal cell carcinoma | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 230 KB)

Published:

03 October 2018

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 371 KB)

Published:

24 August 2018
Committee papers (PDF 2.2 MB)

Published:

24 August 2018
Public committee slides (PDF 467 KB)

Published:

24 August 2018

Draft guidance

Draft guidance
Appraisal consultation document (PDF 385 KB)

Published:

05 June 2018
Committee papers (PDF 19.33 MB)

Published:

05 June 2018
Public committee slides (PDF 871 KB)

Published:

05 June 2018

Invitation to participate

Final scope (PDF 84 KB)

Published:

05 December 2017
Final matrix (PDF 260 KB)

Published:

05 December 2017
NICE's response to comments on the draft scope and provisional matrix (PDF 117 KB)

Published:

05 December 2017
Equality impact assessment (Scoping) (PDF 172 KB)

Published:

05 December 2017

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (PDF 241 KB)

Published:

05 September 2017
Draft matrix post referral (PDF 261 KB)

Published:

05 September 2017